Advancing Telestroke Care: A Prospective Observational Study

Completed

• Conditions: Stroke

• Registration Number: NCT01226862
• Lead Sponsor: National Stroke Association, United States

Brief Summary

This study will promote the development and economic sustainability of telemedicine for acute stroke treatment.

Detailed Description

The goal of this study is to promote the development and economic sustainability of telemedicine for acute stroke treatment. The study's objectives are 1) to determine if the use of telemedicine consultations for stroke patients will improve their care per guidelines compared to stroke patients treated by control hospitals; and 2) to determine if the care per guidelines provided via telemedicine consultations for stroke patients will be similar or equivalent to care per guidelines provided to stroke patients treated at hub hospitals.

The Advancing Telestroke Care study will establish treatment and outcomes in three distinct study cohorts: hub telemedicine hospital, spoke telemedicine hospital and non-telemedicine control hospital.

Study Timeline

• Study First Submitted: 2010-10-20
• Study First Submitted QC: 2010-10-21
• Study First Posted: 2010-10-22
• Study Start: 2010-12
• Primary Completion: 2013-05
• Status Verified: 2013-12
• Study Completion: 2013-12
• Last Update Submitted: 2013-12-04
• Last Update Posted: 2013-12-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 508

Inclusion Criteria

• Age greater than or equal to 18 years old
• Acute ischemic stroke within 12 hours of stroke onset

Exclusion Criteria

• Life expectancy less than 90 days
• Patient unwilling to participate in study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
IV tPA administration	Day 7/Discharge	Correctness of decisions regarding IV tPA administration in acute stroke

Secondary Outcome Measures

Name	Time	Method
Multiple Study Assessments	Day 7 and/or Day 30 and/or Day 90 and/or at discharge	There are 23 assessments, after stroke, for outcome measures. They include: hospital transfers, treatment with reperfusions therapies, treatment with antiplatelets, hypertension treatment, hyperglycemia treatment, hyperlipidemia treatment, symptomatic ICH, mortality, imaging/diagnostic data, stroke and rehab scale scores, number of hospitalizations since last assessment, hospital LOS, discharge location, number of physician visits, and work status.

Trial Locations

Locations (1)

University of Southern California; 🇺🇸 Los Angeles, California, United States